Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028816
Filing Date
2016-11-10
Accepted
2016-11-10 09:02:41
Documents
80
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20160930.htm 10-Q 1416879
2 EX-31.1 reph-ex311_12.htm EX-31.1 16432
3 EX-31.2 reph-ex312_13.htm EX-31.2 16591
4 EX-31.3 reph-ex313_14.htm EX-31.3 16634
5 EX-32.1 reph-ex321_15.htm EX-32.1 9187
  Complete submission text file 0001564590-16-028816.txt   6374430

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT reph-20160930.xml EX-101.INS 1283703
7 XBRL TAXONOMY EXTENSION SCHEMA reph-20160930.xsd EX-101.SCH 56600
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20160930_cal.xml EX-101.CAL 59308
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20160930_def.xml EX-101.DEF 223593
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20160930_lab.xml EX-101.LAB 432648
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20160930_pre.xml EX-101.PRE 376720
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 161986150
SIC: 2834 Pharmaceutical Preparations